Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 2
2006 1
2008 1
2009 3
2010 3
2011 3
2012 4
2013 5
2014 7
2015 4
2016 6
2017 11
2018 8
2019 9
2020 14
2021 8
2022 10
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR; KEYNOTE-024 Investigators. Reck M, et al. N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8. N Engl J Med. 2016. PMID: 27718847 Free article. Clinical Trial.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9. Lancet. 2020. PMID: 33278935 Clinical Trial.
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Learning From Medical Litigation.
Forrest C, Madden D, O'Sullivan MJ, O'Reilly S. Forrest C, et al. Among authors: o reilly s. JCO Oncol Pract. 2023 Apr;19(4):160-163. doi: 10.1200/OP.22.00763. Epub 2023 Jan 18. JCO Oncol Pract. 2023. PMID: 36652657 No abstract available.
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
Reynolds JV, Preston SR, O'Neill B, Lowery MA, Baeksgaard L, Crosby T, Cunningham M, Cuffe S, Griffiths GO, Parker I, Risumlund SL, Roy R, Falk S, Hanna GB, Bartlett FR, Alvarez-Iglesias A, Achiam MP, Nilsson M, Piessen G, Ravi N, O'Toole D, Johnston C, McDermott RS, Turkington RC, Wahed S, Sothi S, Ford H, Wadley MS, Power D; Neo-AEGIS Investigators and Trial Group. Reynolds JV, et al. Lancet Gastroenterol Hepatol. 2023 Nov;8(11):1015-1027. doi: 10.1016/S2468-1253(23)00243-1. Epub 2023 Sep 18. Lancet Gastroenterol Hepatol. 2023. PMID: 37734399 Free PMC article. Clinical Trial.
Current Irish medicolegal landscape: an unsustainable trajectory.
Forrest C, O'Donoghue K, Collins DC, O'Reilly S. Forrest C, et al. Among authors: o reilly s. BMJ Open Qual. 2023 Aug;12(3):e002433. doi: 10.1136/bmjoq-2023-002433. Epub 2023 Aug 22. BMJ Open Qual. 2023. PMID: 37607759 Free PMC article. Review.
Optimising oncology drug expenditure in Ireland.
Kieran R, Hennessy M, Coakley K, O'Sullivan H, Cronin T, Lynch D, Mulroe E, Cooke K, Collins D, O'Reilly S. Kieran R, et al. Among authors: o reilly s. Ir J Med Sci. 2024 Apr 3. doi: 10.1007/s11845-024-03672-y. Online ahead of print. Ir J Med Sci. 2024. PMID: 38568369 Review.
Trastuzumab Deruxtecan in HER2-Low Breast Cancer.
Carroll HK, Higgins MJ, O'Reilly S. Carroll HK, et al. Among authors: o reilly s. N Engl J Med. 2022 Sep 22;387(12):1144. doi: 10.1056/NEJMc2210368. N Engl J Med. 2022. PMID: 36130005 No abstract available.
Sorafenib-induced tuberculosis reactivation.
Teo M, O'Connor TM, O'Reilly SP, Power DG. Teo M, et al. Among authors: o reilly sp. Onkologie. 2012;35(9):514-6. doi: 10.1159/000341829. Epub 2012 Aug 13. Onkologie. 2012. PMID: 23007150
Delayed onset radiation-induced brachial plexopathy.
Conroy M, Murphy LC, McNamara B, O'Reilly S. Conroy M, et al. Among authors: o reilly s. Breast J. 2020 Oct;26(10):2075-2076. doi: 10.1111/tbj.13927. Epub 2020 Jun 14. Breast J. 2020. PMID: 32535991 No abstract available.
106 results